Quattro Financial Advisors LLC Moderna, Inc. Transaction History

Quattro Financial Advisors LLC

$279 Million
Q1 2025

A detailed history of Quattro Financial Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Quattro Financial Advisors LLC holds 25,000 shares of MRNA stock, worth $641,750. This represents 0.25% of its overall portfolio holdings.

Number of Shares

25,000

Previous 84,600 70.45%

Holding current value

$641,750

Previous $3.52 Million 79.87%

% of portfolio

0.25%

Previous 0.99%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$28.35 - $47.53 $1.69 Million - $2.83 Million	-59,600 Reduced 70.45%	25,000 $708,000
Q4 2024 Jan 28, 2025	BUY	$36.85 - $63.93 $829,125 - $1.44 Million	22,500 Added 36.23%	84,600 $3.52 Million
Q4 2024 Jan 27, 2025	SELL	$36.85 - $63.93 $626 - $1,086	-17 Reduced 29.31%	41 $1,000
Q3 2024 Jan 28, 2025	BUY	$63.64 - $125.14 $3.95 Million - $7.77 Million	62,059 Added 151363.41%	62,100 $4.15 Million
Q3 2024 Oct 16, 2024	SELL	$63.64 - $125.14 $5.54 Million - $10.9 Million	-87,042 Reduced 99.93%	58 $3,000
Q1 2024 Apr 18, 2024	BUY	$85.37 - $115.44 $7.43 Million - $10 Million	87,001 Added 87879.8%	87,100 $9.28 Million
Q4 2023 Jan 30, 2024	SELL	$69.51 - $104.43 $3.98 Million - $5.97 Million	-57,201 Reduced 99.83%	99 $9,000
Q3 2023 Oct 20, 2023	BUY	$96.41 - $126.61 $3.6 Million - $4.72 Million	37,300 Added 186.5%	57,300 $5.92 Million
Q2 2023 Jul 25, 2023	BUY	$118.5 - $160.53 $1.19 Million - $1.61 Million	10,000 Added 100.0%	20,000 $2.43 Million
Q1 2023 Apr 25, 2023	BUY	$135.66 - $197.02 $678,300 - $985,100	5,000 Added 100.0%	10,000 $1.54 Million
Q4 2022 Jan 20, 2023	SELL	$118.38 - $210.04 $591,900 - $1.05 Million	-5,000 Reduced 50.0%	5,000 $0
Q2 2022 Aug 01, 2022	BUY	$117.13 - $176.59 $1.17 Million - $1.77 Million	10,000 New	10,000 $1.43 Million

Others Institutions Holding MRNA

# of Institutions

875

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quattro Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quattro Financial Advisors LLC with notifications on news.

Account

Quattro Financial Advisors LLC Moderna, Inc. Transaction History